Assessment of DOT Spectacles in Chinese Children Extension

Recruiting now · Not applicable

Conditions studied: Juvenile Myopia, Myopia

In brief

This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

Key facts

Study ID

NCT07008001

Run by

SightGlass Vision, Inc.

People needed

175

Starts

2025-08-01

Expected to finish

2026-12-31

Last updated by the study team

2025-12-29

Who can join

Age: 8 and older, up to 16. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Previously a successfully completed participant in the CATHAY study (NCT05562622)
• Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)
• Willingness to participate in the trial for 12 months without contact lens wear or any other myopia management intervention
• The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form

You may not qualify if…

• Known allergy to proparacaine, tetracaine, or tropicamide or cyclopentolate

Where it is running

• Aier Eye Hospital — Changsha, China (enrolling)
• West China Hospital — Chengdu, China (enrolling)
• Fudan University EENT — Shanghai, China (enrolling)
• Tianjin Eye Hospital — Tianjin, China (enrolling)
• Zhongshan Ophthalmic Center — Guangzhou, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.